136 related articles for article (PubMed ID: 20660642)
1. Commentary: like it and lump it? Meta-analysis using individual participant data.
Riley RD
Int J Epidemiol; 2010 Oct; 39(5):1359-61. PubMed ID: 20660642
[No Abstract] [Full Text] [Related]
2. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.
Thompson S; Kaptoge S; White I; Wood A; Perry P; Danesh J;
Int J Epidemiol; 2010 Oct; 39(5):1345-59. PubMed ID: 20439481
[TBL] [Abstract][Full Text] [Related]
3. Assessing risk prediction models using individual participant data from multiple studies.
Pennells L; Kaptoge S; White IR; Thompson SG; Wood AM;
Am J Epidemiol; 2014 Mar; 179(5):621-32. PubMed ID: 24366051
[TBL] [Abstract][Full Text] [Related]
4. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
[TBL] [Abstract][Full Text] [Related]
5. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
; Jackson D; White I; Kostis JB; Wilson AC; Folsom AR; Wu K; Chambless L; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Thompson SG; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi V; Vahtera E; Jousilahti P; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Levy D; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen J; Nyyssönen K; Tuomainen TP; Hedblad B; Engström G; Berglund G; Loewel H; Koenig W; Hense HW; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Iso H; Salomaa V; Harald K; Rasi V; Vahtera E; Jousilahti P; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Despres JP; Dagenais GR; Tunstall-Pedoe H; Lowe GD; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Meade TW; Rudnicka A; Brennan P; Knottenbelt C; Cooper JA; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Lowe GD; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Di Angelantonio E; Kaptoge S; Lewington S; Lowe GD; Sarwar N; Thompson SG; Walker M; Watson S; White IR; Wood AM; Danesh J
Stat Med; 2009 Apr; 28(8):1218-37. PubMed ID: 19222087
[TBL] [Abstract][Full Text] [Related]
6. Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests.
Debray TPA; Moons KGM; Riley RD
Res Synth Methods; 2018 Mar; 9(1):41-50. PubMed ID: 28975717
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis and causality: what about evidence-based biochemistry?
Dominiczak M
Curr Opin Lipidol; 2010 Oct; 21(5):466-8. PubMed ID: 20827080
[No Abstract] [Full Text] [Related]
8. Methods for meta-analysis of individual participant data from Mendelian randomisation studies with binary outcomes.
Burgess S; Thompson SG;
Stat Methods Med Res; 2016 Feb; 25(1):272-93. PubMed ID: 22717643
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic risk factors for coronary heart disease.
Ridker PM; Hennekens CH
Circulation; 1991 Mar; 83(3):1098-100. PubMed ID: 1999016
[No Abstract] [Full Text] [Related]
10. After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart disease.
Silberberg JS
Aust N Z J Med; 1994 Dec; 24(6):717-21. PubMed ID: 7717926
[No Abstract] [Full Text] [Related]
11. Folate and risk of cardiovascular disease. Study results were misinterpreted.
Wald DS; Law M; Morris J; Wald NJ
BMJ; 2003 May; 326(7397):1035; author reply 1035. PubMed ID: 12742933
[No Abstract] [Full Text] [Related]
12. Plasma fibrinogen and coronary heart disease in urban Japanese.
Sato S; Nakamura M; Iida M; Naito Y; Kitamura A; Okamura T; Nakagawa Y; Imano H; Kiyama M; Iso H; Shimamoto T; Komachi Y
Am J Epidemiol; 2000 Sep; 152(5):420-3. PubMed ID: 10981454
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.
Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H
Eur Heart J; 1998 Jan; 19(1):55-62. PubMed ID: 9503176
[TBL] [Abstract][Full Text] [Related]
14. Involvement of plasma fibrinogen in coronary artery disease.
Meade TW
Int J Cardiol; 1992 Dec; 37(3):424-6. PubMed ID: 1468831
[No Abstract] [Full Text] [Related]
15. [Fibrinogen, a cardiovascular risk factor].
Ferrara E; Cucchi G; Sardeo C
Minerva Cardioangiol; 1989 Nov; 37(11):473-5. PubMed ID: 2622536
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy and atherosclerotic events. Commentary is inaccurate.
Sudlow C; Sandercock P; Warlow C
BMJ; 2002 Apr; 324(7342):917. PubMed ID: 11950754
[No Abstract] [Full Text] [Related]
17. Are risk factors for stroke and coronary disease the same?
Qizilbash N
Curr Opin Lipidol; 1998 Aug; 9(4):325-8. PubMed ID: 9739488
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
Rothwell PM; Howard SC; Power DA; Gutnikov SA; Algra A; van Gijn J; Clark TG; Murphy MF; Warlow CP
Stroke; 2004 Oct; 35(10):2300-5. PubMed ID: 15345800
[TBL] [Abstract][Full Text] [Related]
19. HELOW: a program for testing extreme homogeneity in meta-analysis.
Zintzaras E; Ioannidis JP
Comput Methods Programs Biomed; 2014 Nov; 117(2):383-6. PubMed ID: 25023534
[TBL] [Abstract][Full Text] [Related]
20. [Explosion of cardiovascular risks in family practice].
Einecke D
MMW Fortschr Med; 2005 Oct; 147(42):1. PubMed ID: 16281771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
